Adipose tissue and adipokines: for better or worse (Q35695447)

9 August 2017

1 reference

title

Adipose tissue and adipokines: for better or worse (English)

1 reference

9 August 2017

Guerre-Millo M

1

1 reference

9 August 2017

1 February 2004

1 reference

9 August 2017

Diabetes and Metabolism

1 reference

9 August 2017

30

1 reference

9 August 2017

13-19

1 reference

9 August 2017

1

1 reference

Differences in mRNA expression of the proteins secreted by the adipocytes in human subcutaneous and visceral adipose tissues

9 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

An adipocentric view of signaling and intracellular trafficking

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose angiotensinogen is involved in adipose tissue growth and blood pressure regulation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Angiotensinogen-deficient mice exhibit impairment of diet-induced weight gain with alteration in adipose tissue development and increased locomotor activity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Angiotensinogen, angiotensin II and adipose tissue development

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Impact of adipose tissue on plasma plasminogen activator inhibitor-1 in dieting obese women

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Subcutaneous abdominal, but not femoral fat expression of plasminogen activator inhibitor-1 (PAI-1) is related to plasma PAI-1 levels and insulin resistance and decreases after weight loss.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Stromal cells are the main plasminogen activator inhibitor-1-producing cells in human fat: evidence of differences between visceral and subcutaneous deposits.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Nutritionally induced obesity is attenuated in transgenic mice overexpressing plasminogen activator inhibitor-1.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Disruption of the plasminogen activator inhibitor 1 gene reduces the adiposity and improves the metabolic profile of genetically obese and diabetic ob/ob mice.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Influence of PAI-1 on adipose tissue growth and metabolic parameters in a murine model of diet-induced obesity.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipsin: a circulating serine protease homolog secreted by adipose tissue and sciatic nerve

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Critical review of acylation-stimulating protein physiology in humans and rodents

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Acylation stimulating protein (ASP), an adipocyte autocrine: new directions

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Mechanisms involved in the regulation of free fatty acid release from isolated human fat cells by acylation-stimulating protein and insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Reduced body weight, adipose tissue, and leptin levels despite increased energy intake in female mice lacking acylation-stimulating protein.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose tissue as an endocrine and paracrine organ

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Molecular mechanisms of insulin resistance and the role of the adipocyte

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Potential role of TNF-alpha in the pathogenesis of insulin resistance and type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Profiling gene transcription in vivo reveals adipose tissue as an immediate target of tumor necrosis factor-alpha: implications for insulin resistance

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Elevated Levels of Interleukin 6 Are Reduced in Serum and Subcutaneous Adipose Tissue of Obese Women after Weight Loss

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose tissue IL-6 content correlates with resistance to insulin activation of glucose uptake both in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Interleukin-6 induces cellular insulin resistance in hepatocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Suppressor of cytokine signaling-3 (SOCS-3), a potential mediator of interleukin-6-dependent insulin resistance in hepatocytes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Interleukin-6-deficient mice develop mature-onset obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Intracerebroventricular interleukin-6 treatment decreases body fat in rats

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

The hormone resistin links obesity to diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Decreased Resistin Expression in Mice with Different Sensitivities to a High-Fat Diet

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose-derived resistin and gut-derived resistin-like molecule-beta selectively impair insulin action on glucose production

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Resistin / Fizz3 expression in relation to obesity and peroxisome proliferator-activated receptor-gamma action in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Positional cloning of the mouse obese gene and its human homologue

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Identification and expression cloning of a leptin receptor, OB-R

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Direct antidiabetic effect of leptin through triglyceride depletion of tissues.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Leptin stimulates fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Transgenic overexpression of leptin rescues insulin resistance and diabetes in a mouse model of lipoatrophic diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Structure-function studies of the adipocyte-secreted hormone Acrp30/adiponectin. Implications fpr metabolic regulation and bioactivity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adiponectin and development of type 2 diabetes in the Pima Indian population

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adiponectin and protection against type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

The effect of thiazolidinediones on plasma adiponectin levels in normal, obese, and type 2 diabetic subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Regulation of adiponectin by adipose tissue-derived cytokines: in vivo and in vitro investigations in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Induction of adiponectin, a fat-derived antidiabetic and antiatherogenic factor, by nuclear receptors

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adiponectin gene expression and secretion is inhibited by interleukin-6 in 3T3-L1 adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

ACRP30, a new hormone controlling fat and glucose metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macrophages

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Diet-induced insulin resistance in mice lacking adiponectin/ACRP30

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Disruption of adiponectin causes insulin resistance and neointimal formation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Increased beta -oxidation but no insulin resistance or glucose intolerance in mice lacking adiponectin

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Globular adiponectin protected ob/ob mice from diabetes and ApoE-deficient mice from atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Enhanced muscle fat oxidation and glucose transport by ACRP30 globular domain: acetyl-CoA carboxylase inhibition and AMP-activated protein kinase activation

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Endogenous glucose production is inhibited by the adipose-derived protein Acrp30

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Cloning of adiponectin receptors that mediate antidiabetic metabolic effects

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver

1 reference

https://api.crossref.org/works/10.1016%2FS1262-3636%2807%2970084-8

7 January 2021

10.1016/S1262-3636(07)70084-8

Identifiers

DOI

1 reference

9 August 2017

1 reference

PubMed ID

15029093